Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Schellenberg

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Neurology|January 27, 1998
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotypeS Craft, E Peskind, M W Schwartz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 1, 1996
Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's diseaseP J McMillan, J B Leverenz, P Poorkaj, et al.
Archives of Neurology|March 1, 1987
The use of apolipoprotein CII as a genetic marker for myotonic dystrophyT D Bird, M Boehnke, G D Schellenberg, et al.
Annals of Neurology|October 1, 1995
Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's diseaseE Levy-Lahad, A Lahad, E M Wijsman, et al.
Neuropathology and Applied Neurobiology|September 20, 2018
Is APOE ε4 required for Alzheimer's disease to develop in TREM2 p.R47H variant carriers?R Guerreiro, T Orme, A C Naj, et al.
Neurology|April 26, 2001
Increased CSF cortisol in AD is a function of APOE genotypeE R Peskind, C W Wilkinson, E C Petrie, et al.
Journal of the Neurological Sciences|February 13, 2001
Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutationF Baskin, R N Rosenberg, L Iyer, et al.
Neurology|March 1, 1992
Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controlsW A Kukull, T R Hinds, G D Schellenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
The genetics of Alzheimer's diseaseG D Schellenberg, T D Bird, E M Wijsman, et al.
Lancet (London, England)|April 18, 1992
Homozygosity mapping and Werner's syndromeG D Schellenberg, G M Martin, E M Wijsman, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Neurology|January 27, 1998
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotypeS Craft, E Peskind, M W Schwartz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 1, 1996
Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's diseaseP J McMillan, J B Leverenz, P Poorkaj, et al.
Archives of Neurology|March 1, 1987
The use of apolipoprotein CII as a genetic marker for myotonic dystrophyT D Bird, M Boehnke, G D Schellenberg, et al.
Annals of Neurology|October 1, 1995
Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's diseaseE Levy-Lahad, A Lahad, E M Wijsman, et al.
Neuropathology and Applied Neurobiology|September 20, 2018
Is APOE ε4 required for Alzheimer's disease to develop in TREM2 p.R47H variant carriers?R Guerreiro, T Orme, A C Naj, et al.
Neurology|April 26, 2001
Increased CSF cortisol in AD is a function of APOE genotypeE R Peskind, C W Wilkinson, E C Petrie, et al.
Journal of the Neurological Sciences|February 13, 2001
Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutationF Baskin, R N Rosenberg, L Iyer, et al.
Neurology|March 1, 1992
Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controlsW A Kukull, T R Hinds, G D Schellenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
The genetics of Alzheimer's diseaseG D Schellenberg, T D Bird, E M Wijsman, et al.
Lancet (London, England)|April 18, 1992
Homozygosity mapping and Werner's syndromeG D Schellenberg, G M Martin, E M Wijsman, et al.
Pageof 13